NCT07524530 2026-04-16
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Not yet recruiting
Clinical Trials
52 trialsNCT07532746 2026-04-16
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
Kousai Bio Co., Ltd.
Phase 1 Not yet recruiting
NCT07133074 2026-04-13
RENEW-IN
University of Pennsylvania
Phase NA Not yet recruiting
NCT07254793 2026-04-07
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
University of Arizona
Phase 1 Not yet recruiting
NCT07485504 2026-03-20
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc.
Phase 1 Not yet recruiting
NCT07456189 2026-03-06
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
NCT07137481 2026-03-04
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07297160 2026-03-04
CALySSEY
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT07441967 2026-03-02
The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Not yet recruiting
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT07424833 2026-02-20
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ascentage Pharma Group Inc.
Phase 1 Not yet recruiting
NCT07403812 2026-02-11
Assessing DCog Short for Neurotoxicity in CAR-T
Beth Israel Deaconess Medical Center
Phase NA Not yet recruiting
NCT07367997 2026-01-26
CARE-RT
Jinnah Postgraduate Medical Centre
Phase NA Not yet recruiting
NCT07362602 2026-01-23
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Phase EARLY_PHASE1 Not yet recruiting
NCT07362732 2026-01-23
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
Sichuan University
Phase EARLY_PHASE1 Not yet recruiting
NCT07358195 2026-01-22
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Massachusetts General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07316907 2026-01-05
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
Affiliated Hospital of Jiangsu University
Phase 1 Not yet recruiting
NCT07294300 2025-12-19
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06345027 2025-12-16
CASEY
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT07286539 2025-12-16
PEPOH
University of Salamanca
Phase NA Not yet recruiting
NCT07255521 2025-12-15
PREHAB-HSCT
Hospital del Salvador
Phase NA Not yet recruiting
NCT06225050 2025-12-03
HAPLO2022
Miltenyi Biomedicine GmbH
Phase NA Not yet recruiting
NCT07255898 2025-12-01
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07251348 2025-11-26
Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies
Necmettin Erbakan University
Phase NA Not yet recruiting
NCT07018310 2025-11-20
MAHATMAt
Assistance Publique Hopitaux De Marseille
Phase NA Not yet recruiting
NCT07107204 2025-09-17
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Biotroy Therapeutics
Phase 1/2 Not yet recruiting
NCT07179094 2025-09-17
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
Ankara University
Phase NA Not yet recruiting
NCT07145359 2025-08-28
Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation
Halic University
Phase NA Not yet recruiting
NCT07117175 2025-08-12
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT06992934 2025-08-03
TARGETALLO
Centre Hospitalier Universitaire de Nice
Phase NA Not yet recruiting
NCT07047352 2025-07-02
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
Shanghai Jiao Tong University School of Medicine
Phase NA Not yet recruiting
NCT07043894 2025-06-29
Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06843291 2025-02-24
UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)
Augusta University
Phase NA Not yet recruiting
NCT06837389 2025-02-20
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT06817759 2025-02-10
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Ciusss de L'Est de l'Île de Montréal
Phase NA Not yet recruiting
NCT06794320 2025-01-27
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
The University of Hong Kong
Phase NA Not yet recruiting
NCT06792630 2025-01-24
A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Not yet recruiting
NCT06676852 2024-11-06
Primary PC HCT
Massachusetts General Hospital
Phase NA Not yet recruiting
NCT06582186 2024-09-03
VORIPRECI
University Hospital, Grenoble
Phase 4 Not yet recruiting
NCT06528249 2024-07-30
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies
Zhejiang Provincial People's Hospital
Phase 1 Not yet recruiting
NCT06480630 2024-06-28
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT06333509 2024-03-27
Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
CARsgen Therapeutics Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06278896 2024-02-26
END
Brigham and Women's Hospital
Phase 3 Not yet recruiting
NCT06238245 2024-02-20
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade
Beijing 302 Hospital
Phase 2 Not yet recruiting
NCT06180499 2024-02-14
ILDTreg2
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Not yet recruiting
NCT06211751 2024-01-18
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT06029166 2023-09-08
IRAF-ISCM
University Hospital, Caen
Phase NA Not yet recruiting
NCT05602168 2022-11-01
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
Institut Paoli-Calmettes
Phase NA Not yet recruiting
NCT05391490 2022-05-26
KCAT19
University College, London
Phase 1 Not yet recruiting
NCT05054231 2021-10-15
SI-CART
Institut Paoli-Calmettes
Phase NA Not yet recruiting